---
title: "CroíValve secures funding from Horizon Europe EIC Accelerator"
date: "2025-07-03T09:37:55.000Z"
publishedDate: "3 juillet 2025"
summary: "CroíValve, developer of the Duo transcatheter system for the treatment of tricuspid regurgitation (TR), has been awarded funding from Horizon Europe’s European Innovation Council (EIC) Accelerator Programme. Part of the EU’s Horizon Europe 2021–2027 Research and Innovation programme, the EIC Accelerator Programme provides funding to high-potential, high-risk start-ups, scale-ups and subject matter experts."
importance: ""
sourceUrl: "https://cardiovascularnews.com/croivalve-secures-funding-from-horizon-europe-eic-accelerator/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2025-07-03-croivalve-secures-funding-from-horizon-europe-eic-accelerator"
imageUrl: "http://cardiovascularnews.com/wp-content/uploads/sites/14/2024/08/DUO_System_Inside_Heart_Imge_edited.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/croivalve-secures-funding-from-horizon-europe-eic-accelerator/"
---

![CroíValve secures funding from Horizon Europe EIC Accelerator](http://cardiovascularnews.com/wp-content/uploads/sites/14/2024/08/DUO_System_Inside_Heart_Imge_edited.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/croivalve-secures-funding-from-horizon-europe-eic-accelerator/*

## L’essentiel

CroíValve, developer of the Duo transcatheter system for the treatment of tricuspid regurgitation (TR), has been awarded funding from Horizon Europe’s European Innovation Council (EIC) Accelerator Programme. Part of the EU’s Horizon Europe 2021–2027 Research and Innovation programme, the EIC Accelerator Programme provides funding to high-potential, high-risk start-ups, scale-ups and subject matter experts.

## Lien source

https://cardiovascularnews.com/croivalve-secures-funding-from-horizon-europe-eic-accelerator/
